{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T04:19:29Z","timestamp":1764562769893,"version":"3.46.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.oftale.2025.09.010","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:36:46Z","timestamp":1759012606000},"page":"788-792","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Uveitis associated with immunotherapy and its response to monotherapy with difluprednate: A case report"],"prefix":"10.1016","volume":"100","author":[{"given":"C.M.","family":"Ortega","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.T.","family":"P\u00e9rez Bello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.F.","family":"Graizman Kohan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.D.","family":"Eraso Quintero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Stuart Pennington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.M.","family":"Preto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.oftale.2025.09.010_bib0005","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3390\/diagnostics14030336","article-title":"Diagnosing and managing uveitis associated with immune checkpoint inhibitors: a review","volume":"14","author":"Zhang","year":"2024","journal-title":"Diagnostics"},{"key":"10.1016\/j.oftale.2025.09.010_bib0010","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bjophthalmol-2019-314403","article-title":"Local therapy for cancer therapy-associated uveitis: a case series and review of the literature","volume":"104","author":"Venkat","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oftale.2025.09.010_bib0015","first-page":"84","article-title":"Nuevas posibilidades terap\u00e9uticas en melanoma metast\u00e1sico","author":"Luna","year":"2016","journal-title":"Rev Hosp Ital B Aires (2004)"},{"key":"10.1016\/j.oftale.2025.09.010_bib0020","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.oftale.2025.09.010_bib0025","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1158\/1078-0432.CCR-22-3181","article-title":"Corticosteroids and cancer immunotherapy","volume":"29","author":"Goodman","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.oftale.2025.09.010_bib0030","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/14737140.2017.1296765","article-title":"Immune-related ocular toxicities in solid tumor patients treated with immune checkpoint inhibitors: a systematic review","volume":"17","author":"Abdel-Rahman","year":"2017","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.oftale.2025.09.010_bib0035","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1089\/jop.2010.0093","article-title":"Ocular distribution of difluprednate ophthalmic emulsion 0.05% in rabbits","volume":"27","author":"Tajika","year":"2011","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.oftale.2025.09.010_bib0040","first-page":"157","article-title":"Topical difluprednate for the treatment of Harada\u2019s disease","volume":"9","author":"Onishi","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.oftale.2025.09.010_bib0045","doi-asserted-by":"crossref","first-page":"e002261","DOI":"10.1136\/jitc-2020-002261","article-title":"Timing of steroid initiation and response rates to immune checkpoint inhibitors in metastatic cancer","volume":"9","author":"Maslov","year":"2021","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.oftale.2025.09.010_bib0050","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.3390\/cancers14051296","article-title":"Is timing of steroid exposure prior to immune checkpoint inhibitor initiation associated with treatment outcomes in melanoma? A population-based study","volume":"14","author":"Nikita","year":"2022","journal-title":"Cancers (Basel)"}],"container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173579425001665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173579425001665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T03:48:23Z","timestamp":1764560903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173579425001665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":10,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2173579425001665"],"URL":"https:\/\/doi.org\/10.1016\/j.oftale.2025.09.010","relation":{},"ISSN":["2173-5794"],"issn-type":[{"type":"print","value":"2173-5794"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uveitis associated with immunotherapy and its response to monotherapy with difluprednate: A case report","name":"articletitle","label":"Article Title"},{"value":"Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oftale.2025.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedad Espa\u00f1ola de Oftalmolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}